The Company

Deep Tech Company. Challenger Mentality.

We challenge how small optics can be made, so imaging can reach the point of biopsy. LEADOPTIK is a commercial-stage medical company device in San Jose, California.

WHY WE EXIST

The Mission

Lung cancer is the leading cause of cancer death worldwide. The tools to detect it early exist.
The ability to confirm a diagnosis at the point of biopsy, in real time, with certainty, has not existed. Until now.


LEADOPTIK was founded to build the imaging intelligence the lung periphery has never had. Starting with optics. Building toward AI. Committed to making every biopsy smarter.

Leadership and Board

Reza Khorasani, Ph.D

CEO & CO-FOUNDER

LeadOptik was founded to build the imaging intelligence the lung periphery has never had.

‍

Starting with optics. Building toward AI. Committed to making every biopsy smarter.

Jiang You, Ph.D

CSO and CO-FOUNDER

Expert in biomedical optical imaging, specializing in depth-resolved optical imaging, the core technology behind the LIA™ platform. Full-stack experience from hardware and software design through preclinical studies. Previously Senior Optical Systems Engineer at Applied Materials, leading optical metrology for high-end display lithography tools.

Alex Chee, M.D

Chief Medical Officer

10+ years in interventional pulmonology and medical device innovation.

Conrad Burke

Board Member

Entrepreneur and investor at MetaVC Partners, building successful new businesses in renewable energy, communications, nanomaterials, and medtech. 

‍

Milestones

October 2026

RISE Clinical Study Begins at Stanford University

2026

In Use at Five Academic Medical Centers

January 2026

First-in-Human Use at the University of Chicago

December 2025

Two FDA 510(k) Clearences

June 2025

Key Patents Granted Across Three Continents

May 2023

Series Seed Round, Led by MetaVC Partners

Backed by:

We're building something that has never existed. Come be part of it.